Trials / Completed
CompletedNCT04969822
eValuating iDA Selection Ability. The VISA Study.
Will Embryo Selection Through Use of Artificial Intelligence (iDA) Perform Equally Compared to Day 5 Morphology?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,066 (actual)
- Sponsor
- Vitrolife · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A non-inferiority, prospective parallel group, multi-center, randomized controlled trial to investigate whether selection of a single blastocyst for transfer using the deep learning tool, iDA, results in non-inferior clinical pregnancy rate compared to trained embryologists using standard morphology criteria.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | iDAScore® | A system that studies time lapse images obtained from the embryo culture system, Embryoscope, throughout the development to blastocyst. The system uses data acquired from a sequence of embryo images and has taught itself to identify the embryos with the highest likelihood of implanting and leading to fetal heart-beat detection. |
Timeline
- Start date
- 2020-02-20
- Primary completion
- 2023-01-24
- Completion
- 2023-11-01
- First posted
- 2021-07-21
- Last updated
- 2024-12-02
- Results posted
- 2024-12-02
Locations
14 sites across 4 countries: Australia, Denmark, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT04969822. Inclusion in this directory is not an endorsement.